asa guidelines for glp 1 agonists Glucagon-Like Peptide-1 Receptor in Perioperative Care A narrative review of glucagon-like
Description
Survodutide targets GLP-1 and glucagon receptors
The comparison between GLP-1RA and SGLT-2 inhibitors also show no difference in their risk for MACE (RR = 0.98, 95% CI 0.911.07)
Once-weekly semaglutide 7.2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial
Seino Y, Terauchi Y, Osonoi T, Yabe D, Abe N, Nishida T, Zacho J, Kaneko S
